Editorial Policy

1. Purpose

PakVita publishes medicine information for educational use. This policy applies to all editorial content, including medicine pages, comparison pages, and clinical explainers.

2. Source hierarchy

Our citation order is:

1. DRAP guidance and registration data
2. WHO guidance and essential medicine references
3. BNF and equivalent clinical formularies
4. FDA/EMA label documentation where relevant
5. Manufacturer PILs and prescribing information
6. Peer-reviewed journals indexed by PubMed

Social media content and unsourced user-generated claims are excluded from clinical assertions.

3. Writing and review process

Each page follows this workflow: draft by editor, medical review by a licensed reviewer, fact check, and publication. Authorship and reviewer byline are displayed on medicine pages.

4. Review cadence

Medicine pages are re-reviewed at least every six months. Pages affected by regulatory updates or user flags are prioritized for immediate review.

5. Correction policy

Corrections are assessed and actioned within five working days. Material corrections include an updated review date and revision summary in page history.

6. Conflicts of interest

PakVita does not accept payment for favorable medical coverage. Any commercial relationship relevant to a page is disclosed on that page.

7. Use of AI assistance

AI tools may support draft generation and formatting. No clinical page is published without named human editorial review and licensed medical sign-off.

8. Medical disclaimer

PakVita content is educational and does not replace diagnosis or treatment by a qualified clinician.

9. Accessibility commitment

We prioritize plain language, logical heading structure, and readable visual contrast for cross-device and assistive technology use.

10. Feedback channel

Report corrections and source issues on Instagram @pakvitaofficial.